bioMérieux will assess AST/AES results and validate against evolving global antimicrobial susceptibility data collected through the JMI-led SENTRY program.
Increases capabilities and capacity to provide anti-infective testing, assay development and biomaterial production services for highly infectious pathogens.
Vicki Barbur of Battelle discusses real-time microbiology, critical factors determining the rapid method of choice, and accessibility to new technologies
Bastin will be responsible for assigning studies to research teams, working with clients and accreditation bodies to draft and optimize study protocols
The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.
Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience01.28.16